SEC Form 4 · accession 0001437749-15-000259
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Frederick Scharschmidt
Officer — SVP & Chief Medical Officer
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2015 | F | 592 | $24.28 | D | 81,285 | D | |
| Common StockF2 | holding | — | — | — | 54,448 | I | By The Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by Hyperion to satisfy taxes payable in connection with vesting of previously awarded restricted stock units.
- F2Includes 16,682 shares previously held directly by reporting person, which were transferred to the Bruce Frederick Scharschmidt and Peggy Sue Crawford Family Trust dated October 9, 2001, and are now owned indirectly.